Eva María Molina-Trinidad

Dr. Eva María Molina-Trinidad


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2016 in JMIR Rehabilitation and Assistive Technologies
Verified
Journal Article
Open access
CAClaudia Isabel Martinez Alcala
Claudia Isabel Martinez Alcala
PPPatricia Pliego-Pastrana
Patricia Pliego-Pastrana
ARALEJANDRA ROSALES-LAGARDE
ALEJANDRA ROSALES-LAGARDE
JLJs Lopez-Noguerola
Js Lopez-Noguerola
EMEva María Molina-Trinidad
Eva María Molina-Trinidad
The official publisher website of JMIR Publications, the leading eHealth publisher. Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 September 2023 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
CDClara Luisa Domínguez-Delgado
Clara Luisa Domínguez-Delgado
SPSara Pozos-Nonato
Sara Pozos-Nonato
KCKenia Areli Campos-Santander
Kenia Areli Campos-Santander
ABAllyson Amelia Benavides
Allyson Amelia Benavides
SPSandy María Pacheco-Ortin
Sandy María Pacheco-Ortin
EMEva María Molina-Trinidad
Eva María Molina-Trinidad
Background: Nanoparticle formulations development for anti-aging treatment is increasing due to their multifunctional properties. These nanotechnological strategies can target cellular/ molecular pathways of the skin affected by the aging process. However, a review of these strategies is required to discuss their efficacy/safety and establish the needs for further research.Objective: Innovative nanotechnological advances for skin anti-aging/rejuvenation are summarized and discussed in this work.Method: The information in this review was extracted from recent and relevant studies using nanotechnology for anti-aging treatment from scientific databases.Results and Discussion: Results show an enhanced skin anti-aging effect of actives-loaded nanoparticles of next generation (nanostructured lipid carriers, fullerenes, transfersomes, protransfersomes, niosomes, ethosomes, transethosomes, glycerosomes, phytosomes) compared with nanocarriers of first generation or conventional formulations. Anti-aging active ingredients such as, flavonoids (rutin, hesperidin, quercetagetine, quercetin, epigallocatechin-3-gallate, myricetin, silibinin, curcuminoids, isoflavones); vitamins (E, D3, CoQ10); acids (hyaluronic, ascorbic, rosmarinic, gallic); extracts (Citrus sinensis, Tagetes erecta L., Achillea millefolium L., Citrus aurantium L., Glycyrrhiza glabra L., Aloe vera, propolis earned by Apis mellifera); and other compounds (adenosine, beta-glucan, heptapetide DEETGEF, resveratrol, cycloastragenol, melatonin, botulinum toxin, grapeseed oil), have been successfully entrapped into nanoparticles for skin rejuvenation. This encapsulation has improved their solubility, bioavailability, stability, permeability, and effectivity for skin anti-aging, providing a controlled drug release with minimized side effects.Conclusion: Recent studies show a trend of anti-aging herbal active ingredients-loaded nanoparticles, enhancing the moisturizing, antioxidant, regenerating and photoprotective activity of the skin. Suitable safety/shelf-life stability of these novel formulations is key to a successful translation to the clinic/industry.

9 June 2020 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
PCPablo Serrano Castañeda
Pablo Serrano Castañeda
CDClara Luisa Domínguez-Delgado
Clara Luisa Domínguez-Delgado
ICIsabel Marlen Rodríguez Cruz
Isabel Marlen Rodríguez Cruz
LCLuz María Melgoza Contreras
Luz María Melgoza Contreras
EMEva María Molina-Trinidad
Eva María Molina-Trinidad
JCJose Juan Escobar Chavez
Jose Juan Escobar Chavez
Aims: Biodegradable polymeric microneedles containing atorvastatin calcium were developed in order to improve the percutaneous absorption of the drug, useful for the treatment of hypercholesterolemia. Background: The use of physical enhancers like microneedles have shown good results to increase the delivery of drugs through the skin, the use of microneedles has very important advantages for transdermal drug delivery, for example, they are painless, easy to use and safe, they increase time interval of drug activity, dose, and reductions in adverse reactions, they also offer, the facility to remove the system instantly of the skin. Objective: Develop polymer microneedles loaded with a calcium atorvastatin and evaluate them by Differential Scanning Calorimetry (DSC), Scanning Electron Microscopy (SEM), bioadhesion, postwetting- bioadhesion, breaking strength, drug release test and in vitro percutaneous absorption studies to demonstrate the use of microneedles atorvastatin is able to cross the skin. Methods: The microneedles were made with poly (methyl vinyl ether-alt-maleic acid) as biodegradable polymer using the technique of casting in solution in a mold. After solidification these microneedles were characterized by Differential Scanning Calorimetry (DSC), Scanning Electron Microscopy (SEM), bioadhesion, post-wetting-bioadhesion, breaking strength, drug release test and in vitro percutaneous absorption studies. Results: In general, the performances were satisfactory for optimal formulation in terms of DSC with no interactions between drug and excipients, SEM shows microneedles with a conical shape, bioadhesion of 1570 g.f, post wetting-bioadhesion of 1503.4 g.f, breaking strength of 1566.7g.f that is sufficient to disrupt Stratum corneum, good drug release and a flux of 33.4 μg/cm2*h with a tLag of 15.14 h for the in vitro percutaneous absorption. Conclusion: The results indicate that it is possible to generate microneedles to increase the percutaneous absorption of calcium atorvastatin transdermally, with the potential to be used as an alternative to the oral route for the treatment of dyslipidemias.

2 November 2023 in Plants
Verified
Journal Article
Open access
PDF file
GAGeorgina Almaguer
Georgina Almaguer
GAGustavo Almaguer-Vargas
Gustavo Almaguer-Vargas
EMEva María Molina-Trinidad
Eva María Molina-Trinidad
MBMarco Antonio Becerril-Flores
Marco Antonio Becerril-Flores
BMBrenda Montejano
Brenda Montejano
JMJosé Ramón Montejano
José Ramón Montejano
The main objective of research into new therapies is the search for more efficacy and fewer toxic effects in cancer treatments. On one hand, vincristine (VCR) is a chemotherapeutic used in different kinds of tumors. On the other hand, epigallocatechin gallate (EGCG) is a green tea metabolite that has shown an antineoplastic effect in diverse investigations, so the objective of this work is to evaluate the antitumor effects of the EGCG/VCR combination on tumor volume and survival. To achieve this objective, the solid model of lymphoma L5178Y was used in BALB/c mice with different doses of VCR, EGCG, and their combination allowed tumor growth and survival time recording. After tumor collection, measurements, and immunohistochemistry for p53, Bcl2, and Cyclin D1 were performed. The results showed that the EGCG/vincristine combination had a greater antitumor effect than those effects of vincristine and EGCG. It can be attributed to the fact that the greatest inhibition of Bcl2 was present in gathering of EGCG harvest with vincristine. Therefore, the combination of EGCG with vincristine has a better antineoplastic effect by inhibiting tumor development and increasing survival on both substances independently.

1 January 2024 in Revista Colombiana de Entomología
Verified
Journal Article
Open access
PDF file
MBMarco Antonio Becerril-Flores
Marco Antonio Becerril-Flores
ABAna Karen Benítez-Hernández
Ana Karen Benítez-Hernández
ASAntonio Santos-Castañeda
Antonio Santos-Castañeda
MTMaría del Rosario Tovar-Tomás
María del Rosario Tovar-Tomás
EMEva María Molina-Trinidad
Eva María Molina-Trinidad
Triatomines are insect vectors of the flagellate protozoan Trypanosoma cruzi , the causative agent of Chagas disease. This occurs when the triatomine defecates on the skin of the vertebrate host when it bites its host for feeding. This lesion causes the penetration of T. cruzi , whose infective phase is the tripomastigote, and the non-infective replicative phase epimastigote. Although the effects of T. cruzi on the development and survival of different species of triatomine bugs are known, it has not been fully described how the parasite affects many of the species that inhabit Mexico. Therefore, the present study aimed to investigate the effect of the presence of T. cruzi on triatomine development and survival. For this, five triatomines of each instar of each species, Triatoma barberi and Triatoma longipennis , were inoculated, from their second instar to their adult stage, female or male. Each triatomine was infected with 3-5 x10 5 parasites and they were incubated for 100 days and the kinetic of parasites in the feces and T. cruzi phases were recorded. The results showed that T. barberi and T. longipennis development was affected in all stages because of T. cruzi infection. It was greater for T. longipennis , both in its mortality, as well as time to molt in each phase.

29 August 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
GAGeorgina Almaguer
Georgina Almaguer
GAGustavo Almaguer-Vargas
Gustavo Almaguer-Vargas
EMEva María Molina-Trinidad
Eva María Molina-Trinidad
MBMarco Antonio Becerril
Marco Antonio Becerril
BMBrenda Montejano
Brenda Montejano
JMJosé Ramón Montejano
José Ramón Montejano
The search for more efficacy and fewer toxic effects in cancer treatments is the main objective of research into new therapies. Vincristine (VCR) is a chemotherapeutic used in different types of tumors. Epigallocatechin gallate (EGCG) is a green tea metabolite that has shown an antineoplastic effect in different investigations, so the objective of this work was to evaluate the antitumor effect of the EGCG/VCR combination on tumor volume and survival. To achieve this objective, the solid model of lymphoma L5178Y was used in BALB/c mice with different doses of VCR, EGCG and their combination; Tumor grow and survival time were recorded. Once the tumors were obtained, they were measured and immunohistochemistry was performed for p53, Bcl2 and CD1. The results showed that the EGCG/vincristine combination had a greater antitumor effect that vincristine and EGCG. This can be partly attributed to the fact that the greatest Bcl2 inhibition was present in the combination of EGCG with vincristine. Therefore, it can be concluded that the combination of EGCG with vincristine has a better antineoplastic effect by inhibiting tumor development and increasing survival than both substances independently.